Ibadullaeva, Nargiz, et al. “Identification of CXCL9 Chemokine As a Potential Biomarker for Assessing Clinical Severity in COVID-19 Patients”. The Journal of Infection in Developing Countries, vol. 18, no. 05, May 2024, pp. 672-8, doi:10.3855/jidc.18537.